Doesn't seem to be too bad. Less than the royalty rate that would apply if Shionogi data had been used directly in a regulatory filing. Applies in Europe, but not elsewhere.
Still, it'd be nice to see a return royalty from Shionogi over method-of-use improvements. I don't know if that's even possible.
I guess we'll see how the market reacts to the news....my guess it that it won't be too favorably. Certainly news not worthy of reversing the downward trend.
Initial reaction looks like a sigh of relief that this isn't going to be an ongoing legal drain.